Mid*Lands IRB, LLC-First Independent IRB in Kansas Awarded Accreditation for Protecting Research Participants
Mid*Lands IRB
, LLC is pleased to announce that it has been awarded accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) at the September meeting of its Council on Accreditation.
Located in the Kansas City metro area, Mid*Lands is an independent review board (IRB) that protects the rights and welfare of research study participants. Mid*Lands IRB specializes in providing customized, personalized, and responsive services for its client partners. Mid*Lands provides IRB review for clients nationwide for all phases of research in all therapeutic areas. Mid*Lands has extensive experience in multi-site trials, with two Boards that meet weekly.
AAHRPP promotes high-quality research through an accreditation process that helps organizations worldwide strengthen their human research protection programs (HRPPs).
An independent, non-profit accrediting body, AAHRPP uses a voluntary, peer-driven, educational model to ensure that HRPPs meet rigorous standards for quality and protection. To earn accreditation, organizations must provide tangible evidence through policies, procedures, and practices of their commitment to scientifically and ethically sound research and continuous improvement.
As the "gold seal," AAHRPP accreditation offers assurances to research participants, researchers, sponsors, government regulators, and the general public that an HRPP is focused first and foremost on excellence.
"After a tremendous amount of work by both our staff and our IRB Members, Mid*Lands has achieved full accreditation," according to Cathy Owen, CIM, CIP, CCRP, President and CEO of Mid*lands. "The rigorous and comprehensive accreditation mandated by AAHRPP provides Mid*Lands with the ability to achieve even higher levels of protection for human research participants," Ms. Owen said.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
